Kaiima Bio-Agritech and Keteng to Commercialize High-yielding EP™ Corn Varieties

Kaiima Bio-Agritech and Kunshan Keteng Biological Science and Technology recently announced that they have signed an agreement to commercialize new corn varieties for the Chinese market using Kaiima's Enhanced Ploidy (EP™) technology and Keteng's elite germplasm.

In private yield trials performed this year in China, EP™ corn hybrids developed by Kaiima and Keteng showed superiority compared to leading commercial varieties. The first EP™ corn hybrids are expected to be submitted for variety registration in 2015, and commercial seeds should be available as of 2018.

Kaiima's non-GMO, EP™ technology successfully harnesses genomic multiplication in plants, which is considered one of the most important evolutionary processes that occurs naturally in plants. When applied to high-impact food crops, EP™ significantly boosts the plants' productivity. Kaiima partners with leading seed companies who developed elite varieties of high-impact crops, adapted to important growing regions in key agricultural markets.

Kaiima China, a wholly owned subsidiary of the Kaiima Bio-Agritech, was established in 2014 in order to offer the company's food, feed and energy solutions to local growers. In addition to its EP™ technology for row crops, Kaiima also develops elite castor and vegetable hybrid varieties.

"Keteng is a high-tech research enterprise," said Dr. Maolong Lu, General Manager and founder of Kunshan Keteng Biological Science and Technology Co., Ltd. "We focus on creating new breeding material with beneficial traits by using cutting-edge breeding technologies." he added. "Our next step is to deliver the value created by the joint research between Keteng and Kaiima to Chinese growers."